Sign In
Buy IBBQ
$28.90
+0.501 (+1.77%)
At Close: Jun 03, 2026
Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Growth in Short Interest
01:32am, Thursday, 29'th Jan 2026
Invesco Nasdaq Biotechnology ETF (NASDAQ: IBBQ - Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 23,534
5 Undervalued ETFs to Ride on Powell's Market Optimism
11:00am, Thursday, 20'th Mar 2025
The Fed lifted market confidence amid economic uncertainty, leading to a rally in the U.S. stock market.
IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks
11:27pm, Saturday, 21'st Sep 2024
IBBQ is a relatively new U.S. biotech ETF that competes with established peers like IBB and XBI. IBBQ has outperformed both since its June 2021 launch date. However, there are specific risks investors
Biotech Rally in Its Early Innings
10:17am, Tuesday, 05'th Mar 2024
Following a multiyear run of disappointment, biotech stocks and related ETFs are showing signs of life. For the past 90 days ending February 29, the widely observed Nasdaq Biotechnology Index was high
6 Factors to Bet on Wall Street: ETFs to Buy
02:01pm, Monday, 04'th Mar 2024
The Nasdaq Composite and the S&P 500 hit new all-time high Friday. However, there are chances of further rally.
Biotech ETFs Stage Solid Comeback at the Start of 2024
12:47pm, Tuesday, 09'th Jan 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
5 Top-Ranked ETF Winners of December With More Room for Gains
09:46am, Friday, 29'th Dec 2023
Wall Street witnessed an upbeat December due to moderation in inflationary pressures, the likelihood of Fed rate cuts in 2024 and decent corporate earnings.
Time for Gilead Sciences-Heavy ETFs?
03:05pm, Tuesday, 12'th Sep 2023
Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data
09:12am, Friday, 24'th Mar 2023
Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
IBBQ: Healthcare Dashboard For December
05:00am, Sunday, 18'th Dec 2022
The pharmaceuticals/biotechnology subsector has good value and quality scores. The healthcare equipment industry is significantly overvalued.
Why Now Could Be The Time To Consider Neuroscience Investments
04:45am, Saturday, 27'th Aug 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
06:23pm, Wednesday, 03'rd Aug 2022
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i
Pharma & Biotech ETFs at One-Month High: Here's Why
09:20am, Friday, 08'th Jul 2022
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
